Nicotine-induced morphological changes in rat aorta: The protective role of melatonin

Cells Tissues Organs

Volumn 195, Issue 3, 2012, Pages 252-259

  Rodella, Luigi Fabrizio ^a   Rossini, Claudia ^a   Favero, Gaia ^a   Foglio, Eleonora ^a   Loreto, Carla ^b   Rezzani, Rita ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Neointima formation; Rats; Thrombospondin 1; Vascular smooth muscle cells

Indexed keywords

CD31 ANTIGEN; MELATONIN; NICOTINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; MALE; MORPHOLOGY; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; CELLS, CULTURED; IMMUNOHISTOCHEMISTRY; MALE; MELATONIN; MUSCLE, SMOOTH, VASCULAR; NICOTINE; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 84857912024     PISSN: 14226405     EISSN: 14226421     Source Type: Journal    
DOI: 10.1159/000324919     Document Type: Article

References (36)

1. Batlle, M., F. Pérez-Villa, A. Lázaro, E. García-Pras, I. Vallejos, A. Sionis, M.A. Castel, E. Roig (2009) Decreased expression of thrombospondin-1 in failing hearts may favor ventricular remodeling. Transplant Proc 41: 2231-2233.
2. Bonnefoy, A., R. Moura, M.F. Hoylaerts (2008) The evolving role of thrombospondin-1 in hemostasis and vascular biology. Cell Mol Life Sci 65: 713-27.
3. Chalon, S., H. Moreno Jr, N.L. Benowitz, B.B. Hoffman, T.F. Blaschke (2000) Nicotine impairs endothelium-dependent dilatation in human veins in vivo. Clin Pharmacol Ther 67: 391-397. (Pubitemid 30246816)
4. Chieco, P., A. Jonker, C. Melchiorri, G. Vanni, C.J. Van Noorden (1994) A user's guide for avoiding errors in absorbance image cytometry: A review with original experimental observations. Histochem J 26: 1-19. (Pubitemid 24049322)
5. Cucina, A., P. Sapienza, V. Corvino, V. Borrelli, V. Mariani, B. Randone, L. Santoro D'Angelo, A. Cavallaro (2000) Nicotine-induced smooth muscle cell proliferation is mediated through bFGF and TGF- 1. Surgery 127: 316-322. (Pubitemid 30140630)
6. Daniel, C., J. Wiede, H.C. Krutzsch, S.M. Ribeiro, D.D. Roberts, J.E. Murphy-Ullrich, C. Hugo (2004) Thrombospondin-1 is a major activator of TGF- in fibrotic renal disease in the rat in vivo. Kidney Int 65: 459-468. (Pubitemid 38130640)
7. Dominguez-Rodriguez, A., P. Abreu-Gonzalez, J.J. Sanchez-Sanchez, J.C. Kaski, R.J. Reiter (2010) Melatonin and circadian biology in human cardiovascular disease. J Pineal Res 49: 14-22.
8. Esemuede, N., T. Lee, D. Pierre-Paul, B.E. Sumpio, V. Gahtan (2004) The role of thrombospondin-1 in human disease. J Surg Res 122: 135-142. (Pubitemid 39441244)
9. Gaemperli, O., R. Liga, P. Bhamra-Ariza, O. Rimoldi (2010) Nicotine addiction and coronary artery disease: Impact of cessation interventions. Curr Pharm Des 16: 2586-2597.
10. Heeschen, C., J.J. Jang, M. Weis, A. Pathak, S. Kaji, R.S. Hu, P.S. Tsao, F.L. Johnson, J.P. Cooke (2001) Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 7: 833-839. (Pubitemid 32691639)
11. Hugo, C., C. Daniel (2009) Thrombospondin in renal disease. Nephron Exp Nephrol 111: E61-e66.
12. Isenberg, J.S., D.A. Wink, D.D. Roberts (2006) Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses. Cardiovasc Res 71: 785-793. (Pubitemid 44848003)
13. Isenberg, J.S., F. Hyodo, K. Matsumoto, M.J. Romeo, M. Abu-Asab, M. Tsokos, P. Kuppusamy, D.A. Wink, M.C. Krishna, D.D. Roberts (2007) Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation. Blood 109: 1945-1952. (Pubitemid 46348191)
14. Isenberg, J.S., W.A. Frazier, D.D. Roberts (2008) Thrombospondin-1: A physiological regulator of nitric oxide signaling. Cell Mol Life Sci 65: 728-742.
15. Isenberg, J.S., Y. Qin, J.B. Maxhimer, J.M. Sipes, D. Despres, J. Schnermann, W.A. Frazier, D.D. Roberts (2009) Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress. Matrix Biol 28: 110-119.
16. Li, M., N.K. Fukagawa (2010) Age-related changes in redox signaling and VSMC function. Antioxid Redox Signal 12: 641-55.
17. Lindenblatt, N., U. Platz, J. Hameister, E. Klar, M.D. Menger, B. Vollmar (2007) Distinct effects of acute and chronic nicotine application on microvascular thrombus formation and endothelial function in male and female mice. Langenbecks Arch Surg 392: 285-295. (Pubitemid 46675808)
18. Louis, H., P. Lacolley, A. Kakou, V. Cattan, D. Daret, M. Safar, J. Bonnet, J.M. Daniel Lamazière (2006) Early activation of internal medial smooth muscle cells in the rabbit aorta after mechanical injury: Relationship with intimal thickening and pharmacological applications. Clin Exp Pharmacol Physiol 33: 131-138.
19. Newby, A.C., A.B. Zaltsman (2000) Molecular mechanisms in intimal hyperplasia. J Pathol 190: 300-309. (Pubitemid 30141376)
20. Paganelli, M.O., J.E. Tanus-Santos, J.C. Toledo, J.F. do Prado, V. Calegari, H. Moreno Jr (2001) Acute administration of nicotine impairs the hypotensive responses to bradykinin in rats. Eur J Pharmacol 413: 241-246. (Pubitemid 32172997)
21. Paradies, G., G. Petrosillo, V. Paradies, R.J. Reiter, F.M. Ruggiero (2010) Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 48: 297-310.
22. Petrosillo, G., G. Colantuono, N. Moro, F.M. Ruggiero, E. Tiravanti, N. Di Venosa, T. Fiore, G. Paradies (2009) Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am J Physiol Heart Circ Physiol 297: H1487-H1493.
23. Qiu, H., Y. Zhu, Z. Sun, J.P. Trzeciakowski, M. Gansner, C. Depre, R.R. Resuello, F.F. Natividad, W.C. Hunter, G.M. Genin, E.L. Elson, D.E. Vatner, G.A. Meininger, S.F. Vatner (2010) Vascular smooth muscle cell stiffness as a mechanism for increased aortic stiffness with aging. Circ Res 107: 615-619.
24. Reiter, R.J., D.X. Tan, S.D. Paredes, L. Fuentes-Broto (2010) Beneficial effects of melatonin in cardiovascular disease. Ann Med 42: 276-285.
25. Rensen, S.S., P.A. Doevendans, G.J. van Eys (2007) Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J 15: 100-108. (Pubitemid 47253691)
26. Rezzani, R., E. Porteri, C. De Ciuceis, F. Bonomini, L.F. Rodella, S. Paiardi, G.E. Boari, C. Platto, A. Pilu, D. Avanzi, D. Rizzoni, E. Agabiti Rosei (2010) Effects of melatonin and Pycnogenol on small artery structure and function in spontaneously hypertensive rats. Hypertension 55: 1373-1380.
27. Rodella, L.F., F. Filippini, F. Bonomini, R. Bresciani, R.J. Reiter, R. Rezzani (2010a) Beneficial effects of melatonin on nicotine-induced vasculopathy. J Pineal Res 48: 126-132.
28. Rodella, L.F., G. Favero, C. Rossini, E. Foglio, R.J. Reiter, R. Rezzani (2010b) Endothelin-1 as a potential marker of melatonin's therapeutic effects in smoking-induced vasculopathy. Life Sci [Epub ahead of print].
29. Rzucidlo, E.M., K.A. Martin, R.J. Powell (2007) Regulation of vascular smooth muscle cell differentiation. J Vasc Surg 45: A25-A32.
30. Samarakoon, R., P.J. Higgins (2008) Integration of non-SMAD and SMAD signaling in TGF- 1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells. Thromb Haemost 100: 976-983.
31. Shi, Y., J. Massagué (2003) Mechanisms of TGF- signaling from cell membrane to the nucleus. Cell 113: 685-700. (Pubitemid 36724933)
32. Stintzing, S., M. Ocker, A. Hartner, K. Amann, L. Barbera, D. Neureiter (2009) Differentiation patterning of vascular smooth muscle cells (VSMC) in atherosclerosis. Virchows Arch 455: 171-185.
33. Tan, D.X., R. Hardeland, L.C. Manchester, S.D. Paredes, A. Korkmaz, R.M. Sainz, J.C. Mayo, L. Fuentes-Broto, R.J. Reiter (2010) The changing biological roles of melatonin during evolution: From an antioxidant to signals of darkness, sexual selection and fitness. Biol Rev Camb Philos Soc 85: 607-623.
34. Tani, S., P.C. Dimayuga, T. Anazawa, K.Y. Chyu, H. Li, P.K. Shah, B. Cercek (2004) Aberrant antibody responses to oxidized LDL and increased intimal thickening in apoE-/-mice exposed to cigarette smoke. Atherosclerosis 175: 7-14. (Pubitemid 38746904)
35. Tengattini, S., R.J. Reiter, D.X. Tan, M.P. Terron, L.F. Rodella, R. Rezzani (2008) Cardiovascular diseases: Protective effects of melatonin. J Pineal Res 44: 16-25. (Pubitemid 350231106)
36. Willis, A.I., D. Pierre-Paul, B.E. Sumpio, V. Gahtan (2004) Vascular smooth muscle cell migration: Current research and clinical implications. Vasc Endovascular Surg 38: 11-23. (Pubitemid 38140268)